Apexigen America, Inc.
4 clinical trials · Sponsor
◉ Watch Apexigen America, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma (NCT04337931) | Apexigen America, Inc. | 2019-06-12 |
| APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers (NCT03165994) | Apexigen America, Inc. | 2017-10-06 |
Track Apexigen America, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.